| Product Code: ETC9942862 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Dog Vaccine Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Dog Vaccine Market - Industry Life Cycle |
3.4 United Kingdom (UK) Dog Vaccine Market - Porter's Five Forces |
3.5 United Kingdom (UK) Dog Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Dog Vaccine Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 United Kingdom (UK) Dog Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Dog Vaccine Market Revenues & Volume Share, By Duration of Immunity, 2021 & 2031F |
3.9 United Kingdom (UK) Dog Vaccine Market Revenues & Volume Share, By Component, 2021 & 2031F |
4 United Kingdom (UK) Dog Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership and humanization of pets in the UK |
4.2.2 Rising awareness about the importance of pet vaccination for overall health |
4.2.3 Government initiatives promoting responsible pet ownership and vaccination compliance |
4.3 Market Restraints |
4.3.1 Regulatory challenges and stringent approval processes for new vaccines |
4.3.2 Competitive landscape with established players dominating the market |
4.3.3 Pet owners' concerns about vaccine safety and potential side effects |
5 United Kingdom (UK) Dog Vaccine Market Trends |
6 United Kingdom (UK) Dog Vaccine Market, By Types |
6.1 United Kingdom (UK) Dog Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Modified/ Attenuated Live, 2021- 2031F |
6.1.4 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Inactivated (Killed), 2021- 2031F |
6.1.5 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Dog Vaccine Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Canine Distemper, 2021- 2031F |
6.2.3 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Canine Infectious Respiratory Disease Complex (CIRDC), 2021- 2031F |
6.2.4 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Canine Parvovirosis/ Parvovirus Disease, 2021- 2031F |
6.2.5 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Canine Leptospirosis, 2021- 2031F |
6.2.6 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Canine Lyme Disease, 2021- 2031F |
6.2.7 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Infectious Canine Hepatitis, 2021- 2031F |
6.2.8 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Other Diseases, 2021- 2031F |
6.2.9 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Other Diseases, 2021- 2031F |
6.3 United Kingdom (UK) Dog Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.3 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Intranasal, 2021- 2031F |
6.3.4 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Oral, 2021- 2031F |
6.4 United Kingdom (UK) Dog Vaccine Market, By Duration of Immunity |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By 1-year, 2021- 2031F |
6.4.3 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By 3- Year, 2021- 2031F |
6.4.4 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Dog Vaccine Market, By Component |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Combined Vaccines, 2021- 2031F |
6.5.3 United Kingdom (UK) Dog Vaccine Market Revenues & Volume, By Mono Vaccines, 2021- 2031F |
7 United Kingdom (UK) Dog Vaccine Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Dog Vaccine Market Export to Major Countries |
7.2 United Kingdom (UK) Dog Vaccine Market Imports from Major Countries |
8 United Kingdom (UK) Dog Vaccine Market Key Performance Indicators |
8.1 Number of veterinary clinics offering vaccination services |
8.2 Percentage of pet owners opting for vaccination for their dogs |
8.3 Frequency of vaccination campaigns and awareness programs conducted by government or non-profit organizations |
9 United Kingdom (UK) Dog Vaccine Market - Opportunity Assessment |
9.1 United Kingdom (UK) Dog Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Dog Vaccine Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 United Kingdom (UK) Dog Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Dog Vaccine Market Opportunity Assessment, By Duration of Immunity, 2021 & 2031F |
9.5 United Kingdom (UK) Dog Vaccine Market Opportunity Assessment, By Component, 2021 & 2031F |
10 United Kingdom (UK) Dog Vaccine Market - Competitive Landscape |
10.1 United Kingdom (UK) Dog Vaccine Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Dog Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here